Home » Cargill, Diversa Sign Collaboration for Development of Novel Enzymes
Cargill, Diversa Sign Collaboration for Development of Novel Enzymes
Diversa Corporation announced that it has signed an agreement with Cargill Health and Food Technologies to discover and develop novel enzymes for the cost-effective production of a proprietary product. Under the terms of the agreement, Diversa will receive upfront payments and research funding and is entitled to receive milestone payments, license fees, and royalties on products that may be developed.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-11-2005/0003383395&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May